An experimental treatment is offering new hope to patients fighting one of the most aggressive forms of brain cancer.
Researchers at Indiana University Health Neuroscience and the IU Simon Cancer Center are recruiting participants for a clinical study investigating the effectiveness of DCVax-Brain, a customized vaccine made from a patient?s own white blood cells to battle glioblastoma multiforme tumors, also known as GBM. They are one of the most common, and most difficult to treat, types of brain tumors.
The new treatment is customized specifically for each patient.
?(It?s) using the patients? own tumor to create a vaccine. What they do is they take the patient?s cells and either educate or mobilize those cells to attack the patient?s own tumor,? said Dr. Stephanie Wagner, Medical Director of the IU Simon Cancer Center neuro-oncology program.
IU Health is the only site in Indiana offering the treatment. So far, the results have shown the vaccine has the ability to extend a patient?s life expectancy from an average of six months to nearly three years.
If you are interested in joining the study, you can contact Dr. Wagner at 317-962-3172, or email her at swagner@iuhealth.org
More information about the study is available online.
Article source: http://www.fox59.com/news/wxin-experimental-treatment-offers-hope-to-brain-cancer-patients-20120629,0,7038267.column?track=rss
Source: http://cancerkick.com/2012/06/29/experimental-treatment-offers-hope-to-brain-cancer-patients/
pecan pie recipe prince philip sugar cookie recipe sugar cookie recipe how the grinch stole christmas macaroni and cheese festivus
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.